The Centers for Disease Control and Prevention (CDC) endorsed the CDC’s Advisory Committee on Immunization Practice’s (ACIP) recommendation for use of the Pfizer-BioNTech and Moderna COVID-19 vaccines for young children on Saturday, June 18, 2022. This follows the U.S Food and Drug Administration’s (FDA) authorization of the emergency use of Moderna and Pfizer-BioNTech COVID-19 vaccines for the prevention of COVID-19 in children 6 months through 5 years of age and 6 months through 4 years of age, respectively.
The authorization was based on the FDA and ACIP’s evaluation and analysis of the safety, efficacy, and manufacturing data of these vaccines. Prior to authorizing, the FDA consulted an independent advisory committee of experts who overwhelmingly voted in favor of making the vaccines available to children in this age group.
